Skip to main navigation Skip to search Skip to main content

Mini-hearts for disease modeling and drug testing – process optimization versus biological functionality

  • Jana Hecking
  • , Mariel Cano-Jorge
  • , Robert Passier
  • , José Manuel Rivera-Arbeláez*
  • *Corresponding author for this work

Research output: Contribution to journal › Short survey › Academic › peer-review

31 Downloads (Pure)

Abstract

Traditional two-dimensional cell cultures and in vivo animal studies fail to fully recapitulate human cardiac physiology, highlighting the urgent need for more relevant human-based models. Engineered three-dimensional cardiac systems - including organoids, engineered heart tissues, and heart-on-chip platforms offer promising alternatives, providing structural and functional insights into cardiac biology. However, a critical limitation of these models is their inability to perform fluid pumping and relaxation, which together define fundamental heart function. Engineered cardiac chambers have emerged to address this gap, enabling physiologically relevant pressure-volume measurements and capturing both contractile and diastolic dynamics that mimic aspects of native cardiac hemodynamics. This mini-review examines the current state of engineered cardiac chambers and highlights their main design features. We discuss their applications in disease modeling and drug testing, and outline key factors influencing the optimization of these models, including balancing biological fidelity with process efficiency through modular design principles. Overall, engineered cardiac chambers represent a unique, powerful platform to improve mechanistic understanding of cardiac disease, offering significant potential to advance cardiovascular research and therapeutic development.

Original languageEnglish
Article number1719533
Number of pages8
JournalFrontiers in bioengineering and biotechnology
Volume13
DOIs
Publication statusE-pub ahead of print/First online - 5 Jan 2026

Keywords

  • 3D cardiac models
  • Disease modeling
  • Drug testing
  • Engineered cardiac chambers
  • Tissue engineering

Fingerprint

Dive into the research topics of 'Mini-hearts for disease modeling and drug testing – process optimization versus biological functionality'. Together they form a unique fingerprint.

Cite this